Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2016
"Glial
Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic
Factor or GDNF) - Pipeline Review, H2 2016"
The Report covers current Market Trends, Worldwide Analysis, Global
Forecast, Review, Share, Size, Growth, Effect.
Description-
Global
Markets Directs, Glial Cell Line Derived Neurotrophic Factor
(Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2
2016, provides in depth analysis on Glial Cell Line Derived
Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF)
targeted pipeline therapeutics.
The
report provides comprehensive information on the Glial Cell Line
Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or
GDNF) , targeted therapeutics, complete with analysis by indications,
stage of development, mechanism of action (MoA), route of
administration (RoA) and molecule type.
The
report also covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and
latest news and press releases. Additionally, the report provides an
overview of key players involved in Glial Cell Line Derived
Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF)
targeted therapeutics development and features dormant and
discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
Scope
-
The report provides a snapshot of the global therapeutic landscape
for Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived
Trophic Factor or GDNF)
-
The report reviews Glial Cell Line Derived Neurotrophic Factor
(Astrocyte Derived Trophic Factor or GDNF) targeted therapeutics
under development by companies and universities/research institutes
based on information derived from company and industry-specific
sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved in Glial Cell Line Derived
Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF)
targeted therapeutics and enlists all their major and minor projects
-
The report assesses Glial Cell Line Derived Neurotrophic Factor
(Astrocyte Derived Trophic Factor or GDNF) targeted therapeutics
based on mechanism of action (MoA), route of administration (RoA) and
molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news and deals related to Glial Cell Line
Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or
GDNF) targeted therapeutics
Reasons
to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand the targeted therapy areas and indications
for Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived
Trophic Factor or GDNF)
-
Identify the use of drugs for target identification and drug
repurposing
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived
Trophic Factor or GDNF) development landscape
Comments
Post a Comment